|
About the Division of Pharmacologic TherapiesThe Division of Pharmacologic Therapies (DPT) is a division of the Center for Substance Abuse Treatment (CSAT) within the Substance Abuse and Mental Health Services Administration. DPT manages the day-to-day regulatory oversight activities necessary to implement SAMHSA regulations 42 CFR Part 8, on the use of opioid agonist medications (methadone, LAAM and buprenorphine) approved by the Food and Drug Administration for addiction treatment. These activities include supporting the certification and accreditation of over 1,250 opioid treatment programs (i.e., methadone clinics) that collectively treat over 300,000 patients annually. DPT also implements the Drug Addiction Treatment Act of 2000 (DATA 2000), which expands the clinical context of medication-assisted opioid addiction treatment by allowing qualified physicians to dispense or prescribe specifically approved Schedule III, IV, and V narcotic medications for the treatment of opioid addiction in treatment settings other than the traditional opioid treatment program. Additionally, DPT supports the training of medical and substance abuse professionals on a variety of treatment issues, including the use of medications, such as buprenorphine. Contact UsTelephone:
Voice: (240) 276-2700 Email:otp-extranet@opioid.samhsa.govMail Address:Center for Substance Abuse TreatmentDivision of Pharmacologic Therapies Substance Abuse and Mental Health Services Administration 1 Choke Cherry Road Room 7-1035 Rockville, MD 20857 Overnight Address:Center for Substance Abuse TreatmentDivision of Pharmacologic Therapies Substance Abuse and Mental Health Services Administration 1 Choke Cherry Road Room 7-1035 Rockville, Maryland 20850 Staff Information
Robert Lubran, MS, MPA
Director
|
